| Connor William Kimbrell, MD | |
|
975 E 3rd St, Chattanooga, TN 37403-2147 | |
| (423) 778-7628 | |
| Not Available |
| Full Name | Connor William Kimbrell |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 5 Years |
| Location | 975 E 3rd St, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497217038 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0000063128 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tennessee River Physicians, Pllc | 8022387349 | 65 |
News Archive
CeNeRx BioPharma, Inc., today announced that a new formulation of TriRima, its lead agent for treatment resistant depression, showed excellent safety in a study designed to test whether it is free of the food-induced cardiovascular effects associated with conventional MAO inhibitors.
According to a new study babies fed starchy table foods, which often contain added salt, before 6 months of age show a preference for salt that persists through their preschool years.
New data presented at the International Liver CongressTM today show the existence of novel interactions between T cells and hepatocytes that are regulated by HCV infection, providing a novel understanding of how HCV persists in the liver.
Hard to Treat Diseases (the "Company") announced today, that its China based subsidiary Mellow Hope, has just finished (August 2009) the clinical trial of Cerebroprotein Hydrolysate for Injection (Brand name: NUTRIPROTEIN) in India.
› Verified 2 days ago
| Entity Name | Tennessee River Physicians, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396282463 PECOS PAC ID: 8022387349 Enrollment ID: O20170629002555 |
News Archive
CeNeRx BioPharma, Inc., today announced that a new formulation of TriRima, its lead agent for treatment resistant depression, showed excellent safety in a study designed to test whether it is free of the food-induced cardiovascular effects associated with conventional MAO inhibitors.
According to a new study babies fed starchy table foods, which often contain added salt, before 6 months of age show a preference for salt that persists through their preschool years.
New data presented at the International Liver CongressTM today show the existence of novel interactions between T cells and hepatocytes that are regulated by HCV infection, providing a novel understanding of how HCV persists in the liver.
Hard to Treat Diseases (the "Company") announced today, that its China based subsidiary Mellow Hope, has just finished (August 2009) the clinical trial of Cerebroprotein Hydrolysate for Injection (Brand name: NUTRIPROTEIN) in India.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Connor William Kimbrell, MD 975 E 3rd St, Chattanooga, TN 37403-2147 Ph: () - | Connor William Kimbrell, MD 975 E 3rd St, Chattanooga, TN 37403-2147 Ph: (423) 778-7628 |
News Archive
CeNeRx BioPharma, Inc., today announced that a new formulation of TriRima, its lead agent for treatment resistant depression, showed excellent safety in a study designed to test whether it is free of the food-induced cardiovascular effects associated with conventional MAO inhibitors.
According to a new study babies fed starchy table foods, which often contain added salt, before 6 months of age show a preference for salt that persists through their preschool years.
New data presented at the International Liver CongressTM today show the existence of novel interactions between T cells and hepatocytes that are regulated by HCV infection, providing a novel understanding of how HCV persists in the liver.
Hard to Treat Diseases (the "Company") announced today, that its China based subsidiary Mellow Hope, has just finished (August 2009) the clinical trial of Cerebroprotein Hydrolysate for Injection (Brand name: NUTRIPROTEIN) in India.
› Verified 2 days ago
Joseph Kerby Gray, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 2525 De Sales Ave, Chattanooga, TN 37404 Phone: 423-495-2525 | |
Ronald A. Gracy Ii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 941 Spring Creek Rd, Chattanooga, TN 37412 Phone: 423-894-7870 Fax: 865-539-8008 | |
Dr. Jocelyn May De Guzman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1755 Gunbarrel Rd, Chattanooga, TN 37421 Phone: 423-680-8534 | |
Dr. Jeffrey Durant Clinkscales, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-7628 | |
Dr. Shelley L Murphy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1018 Blackford Street, Chattanooga, TN 37403 Phone: 423-778-7000 | |
Samuel Wilson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 Desales Ave, Chattanooga, TN 37404 Phone: 423-697-0014 Fax: 423-648-6280 | |
Dr. James B Bardoner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-7296 Fax: 423-778-8086 |